An Evaluation of the Safety and Performance of the CathVision Cube® System

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 2, 2020

Primary Completion Date

July 9, 2021

Study Completion Date

August 1, 2021

Conditions
Cardiac Arrhythmia
Interventions
PROCEDURE

EP Procedure

Intracardiac signals will be passively recorded using CathVision Cube® System in parallel with the commercial (CE marked) EP recording system during a scheduled electrophysiology procedure

Trial Locations (2)

2100

Rigshospitalet, Copenhagen

14021 Praha 4

IKEM, Institue of Clinical and Experimental Medicine, Prague

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

TRIQ GROUP Wherry & Klaffke GbR

UNKNOWN

lead

CathVision ApS

INDUSTRY

NCT05114382 - An Evaluation of the Safety and Performance of the CathVision Cube® System | Biotech Hunter | Biotech Hunter